IGF2 p.Val67Ile
c.199G>A · rs1564894953 · VCV1328522
Computational evidence
| Protein change | ||
| AlphaMissense | 0.4862 | ambiguous |
|---|---|---|
| REVEL | 0.711 | pathogenic-leaning |
| SaProt | LLR -10.62 | damaging |
| ⇒ REVEL and SaProt both call this damaging; AlphaMissense is indeterminate. | ||
| Splicing | ||
| SpliceAI | Δ0.24 | acceptor gain · deltas |
| Constraint at this position | ||
| Conservation | phyloP 7.3 | GERP 1.4, phastCons 1 |
| Regional constraint | o/e 0.38 | unconstrained · MANE · 1,851 bp · p 3.2e-08 · regional, not allelic |
| Overall | ||
| CADD | 27.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,492 |
| European (non-Finnish)grpmax | 0.000169% | 589,998 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- IGF2
- Protein
- p.Val67Ile
- Coding
- c.199G>A
- MANE Select
- NM_000612
- dbSNP
- rs1564894953
- Type
- single nucleotide variant
- Location
- chr11:2133624 (GRCh38)
- Gene constraint
- LOEUF 0.496 · pLI 0.96 · ClinGen HI 0/3 (gnomAD)
- Structure
- AlphaFold pLDDT 58.95 · 16 PDB
- Residue 67
- a UniProt-annotated variant site (in srs3); an α-helix; the 'a' region
Disease context
Silver-Russell syndrome 3 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Silver-Russell syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Not applicable
- Onset
- Antenatal, Neonatal
- Prevalence
- 1-5 / 10 000 (Europe)
Similar variants
- IGF2 p.Gly34Cys Likely pathogenic ★★ same condition
- IGF2 p.Ser20Ter Likely pathogenic ★★ same condition
- IGF2 p.Arg138Trp Uncertain significance ★★ ⚠ same condition
- IGF2 p.Arg156Cys Uncertain significance ★★ ⚠ same condition
- IGF2 p.Gly2Glu Uncertain significance ★★ ⚠ same condition
- IGF2 p.Gly35Arg Uncertain significance ★★ ⚠ same condition
- IGF2 p.Met1Val Uncertain significance ★★ same condition
- IGF2 p.Met5Val Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/igf2-p-val67ile (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown